Increased Granulocyte Membrane Neprilysin (CD10) Expression is Associated with Better Prognosis in Heart Failure

Overview

Journal Eur J Heart Fail

Publisher Wiley

Specialty Cardiology & Vascular Diseases

Date 2019 Mar 5

PMID 30828920

Citations 4

Authors

Noemi Pavo

Alfred Gugerell

Georg Goliasch

Philipp Emanuel Bartko

Henrike Arfsten

Johannes Franz Novak

Mariann Gyongyosi

Martin Hulsmann

Affiliations

Soon will be listed here.

Citing Articles

IGF2BP1 Enhances Neprilysin mRNA Stability to Promote Proliferation, Invasion, and Angiogenesis in Placental Trophoblasts.

Fan C, Zhou H, Pan Y, Lu D Int J Gen Med. 2025; 18:967-980.

PMID: 40026808 PMC: 11869756. DOI: 10.2147/IJGM.S507410.

A comprehensive review of the literature on CD10: its function, clinical application, and prospects.

Wang S, Xiao Y, An X, Luo L, Gong K, Yu D Front Pharmacol. 2024; 15:1336310.

PMID: 38389922 PMC: 10881666. DOI: 10.3389/fphar.2024.1336310.

Relevance of Neutrophil Neprilysin in Heart Failure.

Prausmuller S, Spinka G, Arfsten H, Stasek S, Rettl R, Bartko P Cells. 2021; 10(11).

PMID: 34831146 PMC: 8616455. DOI: 10.3390/cells10112922.

Neprilysin as a Biomarker: Challenges and Opportunities.

Pavo N, Prausmuller S, Bartko P, Goliasch G, Hulsmann M Card Fail Rev. 2020; 6:e23.

PMID: 32944293 PMC: 7479538. DOI: 10.15420/cfr.2019.21.

MUW researcher of the month.

Arfsten H Wien Klin Wochenschr. 2020; 132(7-8):219-220.

PMID: 32318860 DOI: 10.1007/s00508-020-01656-3.

References

Martens A, Eppink G, Woittiez A, Eidhof H, de Leij L . Neutrophil function capacity to express CD10 is decreased in patients with septic shock. Crit Care Med. 1999; 27(3):549-53. DOI: 10.1097/00003246-199903000-00034. View

Boileau G, Giguere V, Letarte M . Comparative levels of CALLA/neutral endopeptidase on normal granulocytes, leukemic cells, and transfected COS-1 cells. Blood. 1990; 76(4):775-82. View

McMurray J, Packer M, Desai A, Gong J, Lefkowitz M, Rizkala A . Angiotensin-neprilysin inhibition versus enalapril in heart failure. N Engl J Med. 2014; 371(11):993-1004. DOI: 10.1056/NEJMoa1409077. View

Vodovar N, Seronde M, Laribi S, Gayat E, Lassus J, Januzzi Jr J . Elevated Plasma B-Type Natriuretic Peptide Concentrations Directly Inhibit Circulating Neprilysin Activity in Heart Failure. JACC Heart Fail. 2015; 3(8):629-36. DOI: 10.1016/j.jchf.2015.03.011. View

Bayes-Genis A, Barallat J, Richards A . A Test in Context: Neprilysin: Function, Inhibition, and Biomarker. J Am Coll Cardiol. 2016; 68(6):639-653. DOI: 10.1016/j.jacc.2016.04.060. View